Literature DB >> 19452521

Longitudinal MRI monitoring of brain damage in the neonatal ventral hippocampal lesion rat model of schizophrenia.

Jean-Baptiste Bertrand1, Jean-Baptiste Langlois, Mélina Bégou, Julien Volle, Philippe Brun, Thierry d'Amato, Mohamed Saoud, Marie-Françoise Suaud-Chagny.   

Abstract

Rat with excitotoxic neonatal ventral hippocampal lesions (NVHL rats) is considered as a heuristic neurodevelopmental model for studying schizophrenia. Extensive study of this model is limited by the lack of clear validity criteria of such lesions and because ascertaining of the lesions is realized postmortem with histological examination after completing experiments. Here, in a first experiment, by assessing the locomotor response to amphetamine in adult NVHL rats, we further specify that the lesions must be bilateral and confined to the ventral hippocampus to obtain the validated behavioral phenotype. We then show a longitudinal magnetic resonance imaging (MRI) protocol suitable for the detection of brain structural changes in NVHL rats. The T(2)-weighted images acquired in adult NVHL rats reveal the same structural changes as those appraised with histological protocol. Moreover, we demonstrate that the lesion status in adulthood can be accurately predicted from the T(2)-weighted images acquired in the juvenile period. As technical advantages, our MRI protocol makes possible to select animals according to lesion criteria as soon as in the juvenile period before long-lasting experiments and gives access in vivo to a quantitative parameter indicative of the lesion extent. Finally, we show that the lesion size increases only slightly between juvenile and adult periods. These latter results are discussed in the context of the specific postpubertal emergence of the behavioral deficits in NVHL rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19452521     DOI: 10.1002/hipo.20628

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  7 in total

Review 1.  Epigenetics and biomarkers in the staging of neuropsychiatric disorders.

Authors:  Trevor Archer; Richard J Beninger; Tomas Palomo; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 2.  Models of neurodevelopmental abnormalities in schizophrenia.

Authors:  Susan B Powell
Journal:  Curr Top Behav Neurosci       Date:  2010

3.  Longitudinal characterization of brain atrophy of a Huntington's disease mouse model by automated morphological analyses of magnetic resonance images.

Authors:  Jiangyang Zhang; Qi Peng; Qing Li; Neda Jahanshad; Zhipeng Hou; Mali Jiang; Naoki Masuda; Douglas R Langbehn; Michael I Miller; Susumu Mori; Christopher A Ross; Wenzhen Duan
Journal:  Neuroimage       Date:  2009-10-19       Impact factor: 6.556

4.  The HDAC Inhibitor Phenylbutyrate Reverses Effects of Neonatal Ventral Hippocampal Lesion in Rats.

Authors:  Guy Sandner; Lionel Host; Marie-Josée Angst; Thierry Guiberteau; Blandine Guignard; Jean Zwiller
Journal:  Front Psychiatry       Date:  2011-01-07       Impact factor: 4.157

5.  MR brain volumetric measurements are predictive of neurobehavioral impairment in the HIV-1 transgenic rat.

Authors:  Rafael Casas; Siva Muthusamy; Paul G Wakim; Sanhita Sinharay; Margaret R Lentz; William C Reid; Dima A Hammoud
Journal:  Neuroimage Clin       Date:  2017-11-21       Impact factor: 4.881

6.  Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats.

Authors:  Eva Drazanova; Jana Ruda-Kucerova; Lucie Kratka; Tibor Stark; Martin Kuchar; Michal Maryska; Filippo Drago; Zenon Starcuk; Vincenzo Micale
Journal:  Sci Rep       Date:  2019-04-15       Impact factor: 4.379

7.  Effects of caffeine or RX821002 in rats with a neonatal ventral hippocampal lesion.

Authors:  Guy Sandner; Marie-Josée Angst; Thierry Guiberteau; Blandine Guignard; Astrid Nehlig
Journal:  Front Behav Neurosci       Date:  2014-01-28       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.